KURE holdings
KraneShares MSCI All China Health Care Index ETF
Positions
63 stored of 63 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BeOne Medicines AG BEONE MEDICINES LTD-H COMMON STOCK | CH1391448177 | H0743H114 | 8.844% | $6.3M | Equity (common) | Other | Hong Kong | HKD |
| 2 | INNOVENT BIOLOGICS, INC. INNOVENT BIOLOGICS INC COMMON STOCK | KYG4818G1010 | Not reported | 8.800% | $6.3M | Equity (common) | Other | Hong Kong | HKD |
| 3 | WUXI BIOLOGICS (CAYMAN) INC. WUXI BIOLOGICS CAYMAN INC COMMON STOCK | KYG970081173 | Not reported | 7.512% | $5.4M | Equity (common) | Other | Hong Kong | HKD |
| 4 | WuXi AppTec Co., Ltd. WUXI APPTEC CO LTD-A COMMON STOCK | CNE1000031K4 | Not reported | 5.787% | $4.1M | Equity (common) | Other | China | CNY |
| 5 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd JIANGSU HENGRUI PHARMACEUT-A COMMON STOCK | CNE0000014W7 | Not reported | 4.590% | $3.3M | Equity (common) | Other | China | CNY |
| 6 | Shenzhen Mindray Bio-Medical Electronics Co Ltd SHENZHEN MINDRAY BIO-MEDIC-A COMMON STOCK | CNE100003G67 | Not reported | 4.275% | $3.0M | Equity (common) | Other | China | CNY |
| 7 | Akeso Inc AKESO INC COMMON STOCK | KYG0146B1032 | Not reported | 3.720% | $2.6M | Equity (common) | Other | Hong Kong | HKD |
| 8 | CSPC PHARMACEUTICAL GROUP LIMITED CSPC PHARMACEUTICAL GROUP LT COMMON STOCK | HK1093012172 | Not reported | 3.680% | $2.6M | Equity (common) | Other | Hong Kong | HKD |
| 9 | Invesco Government & Agency Portfolio | US8252528851 | 825252885 | 3.548% | $2.5M | Short-term investment vehicles (cash funds) | Other | United States | USD |
| 10 | SINO BIOPHARMACEUTICAL LIMITED SINO BIOPHARMACEUTICAL COMMON STOCK | KYG8167W1380 | Not reported | 3.385% | $2.4M | Equity (common) | Other | Hong Kong | HKD |
| 11 | WuXi AppTec Co., Ltd. WUXI APPTEC CO LTD-H COMMON STOCK | CNE100003F19 | Not reported | 3.351% | $2.4M | Equity (common) | Other | Hong Kong | HKD |
| 12 | HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED HANSOH PHARMACEUTICAL GROUP COMMON STOCK | KYG549581067 | Not reported | 2.853% | $2.0M | Equity (common) | Other | Hong Kong | HKD |
| 13 | 3SBio Inc. 3SBIO INC COMMON STOCK | KYG8875G1029 | Not reported | 2.487% | $1.8M | Equity (common) | Other | Hong Kong | HKD |
| 14 | YUNNAN BAIYAO GROUP CO., LTD YUNNAN BAIYAO GROUP CO LTD-A COMMON STOCK | CNE0000008X7 | Not reported | 2.305% | $1.6M | Equity (common) | Other | China | CNY |
| 15 | Shanghai United Imaging Healthcare Co., Ltd. SHANGHAI UNITED IMAGING HE-A COMMON STOCK | CNE100005PN5 | Not reported | 2.272% | $1.6M | Equity (common) | Other | China | CNY |
| 16 | Aier Eye Hospital Group Co., Ltd. AIER EYE HOSPITAL GROUP CO-A COMMON STOCK | CNE100000GR6 | Not reported | 2.098% | $1.5M | Equity (common) | Other | China | CNY |
| 17 | Sichuan Biokin Pharmaceutical Co Ltd SICHUAN BIOKIN PHARMACEUTI-A COMMON STOCK | CNE100006FN4 | Not reported | 1.966% | $1.4M | Equity (common) | Other | China | CNY |
| 18 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd SICHUAN KELUN-BIOTECH BIOP-H COMMON STOCK | CNE1000062J1 | Not reported | 1.851% | $1.3M | Equity (common) | Other | Hong Kong | HKD |
| 19 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. ZHANGZHOU PIENTZEHUANG PHA-A COMMON STOCK | CNE000001F21 | Not reported | 1.734% | $1.2M | Equity (common) | Other | China | CNY |
| 20 | SINOPHARM GROUP CO. LTD. SINOPHARM GROUP CO-H COMMON STOCK | CNE100000FN7 | Not reported | 1.671% | $1.2M | Equity (common) | Other | Hong Kong | HKD |
| 21 | Sichuan Kelun Pharmaceutical Co., Ltd. SICHUAN KELUN PHARMACEUTIC-A COMMON STOCK | CNE100000PW7 | Not reported | 1.546% | $1.1M | Equity (common) | Other | China | CNY |
| 22 | Haisco Pharmaceutical Group Co., Ltd. HAISCO PHARMACEUTICAL GROU-A COMMON STOCK | CNE100001BC7 | Not reported | 1.526% | $1.1M | Equity (common) | Other | China | CNY |
| 23 | HUADONG MEDICINE CO., LTD HUADONG MEDICINE CO LTD-A COMMON STOCK | CNE0000011S1 | Not reported | 1.361% | $969K | Equity (common) | Other | China | CNY |
| 24 | WuXi XDC Cayman Inc WUXI XDC CAYMAN INC COMMON STOCK | KYG9808A1058 | Not reported | 1.353% | $964K | Equity (common) | Other | Hong Kong | HKD |
| 25 | Shanghai Allist Pharmaceuticals Co Ltd SHANGHAI ALLIST PHARMACEUT-A COMMON STOCK | CNE100005XJ7 | Not reported | 1.340% | $954K | Equity (common) | Other | China | CNY |
| 26 | Legend Biotech Corp LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT | US52490G1022 | 52490G102 | 1.277% | $909K | Equity (common) | Other | United States | USD |
| 27 | RemeGen Co Ltd REMEGEN CO LTD-A COMMON STOCK | CNE100005B03 | Not reported | 1.259% | $896K | Equity (common) | Other | China | CNY |
| 28 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. SHANGHAI FOSUN PHARMACEUTI-A COMMON STOCK | CNE000000X38 | Not reported | 1.239% | $882K | Equity (common) | Other | China | CNY |
| 29 | Pharmaron Beijing Co., Ltd. PHARMARON BEIJING CO LTD-A COMMON STOCK | CNE100003JW4 | Not reported | 1.148% | $818K | Equity (common) | Other | China | CNY |
| 30 | Shanghai Pharmaceuticals Holding Co., Ltd. SHANGHAI PHARMACEUTICALS-A COMMON STOCK | CNE000000C82 | Not reported | 1.133% | $807K | Equity (common) | Other | China | CNY |
| 31 | Genscript Biotech Corp GENSCRIPT BIOTECH CORP COMMON STOCK | KYG3825B1059 | Not reported | 1.112% | $792K | Equity (common) | Other | Hong Kong | HKD |
| 32 | RemeGen Co Ltd REMEGEN CO LTD-H COMMON STOCK | CNE1000048G6 | Not reported | 1.051% | $748K | Equity (common) | Other | Hong Kong | HKD |
| 33 | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. CHINA RESOURCES SANJIU MED-A COMMON STOCK | CNE0000011K8 | Not reported | 1.027% | $731K | Equity (common) | Other | China | CNY |
| 34 | XtalPi Holdings Limited XTALPI HOLDINGS LTD COMMON STOCK | KYG7S12M1051 | Not reported | 0.996% | $709K | Equity (common) | Other | Hong Kong | HKD |
| 35 | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. SHENZHEN SALUBRIS PHARM-A COMMON STOCK | CNE100000FW8 | Not reported | 0.938% | $668K | Equity (common) | Other | China | CNY |
| 36 | Shenzhen New Industries Biomedical Engineering Co Ltd SHENZHEN NEW INDUSTRIES BI-A COMMON STOCK | CNE100003T39 | Not reported | 0.903% | $643K | Equity (common) | Other | China | CNY |
| 37 | BEIJING TONG REN TANG CO., LTD BEIJING TONG REN TANG CO-A COMMON STOCK | CNE000000R69 | Not reported | 0.863% | $614K | Equity (common) | Other | China | CNY |
| 38 | Shanghai RAAS Blood Products Co., Ltd. SHANGHAI RAAS BLOOD PRODUC-A COMMON STOCK | CNE100000C31 | Not reported | 0.786% | $560K | Equity (common) | Other | China | CNY |
| 39 | Chongqing Zhifei Biological Products Co., Ltd. CHONGQING ZHIFEI BIOLOGICA-A COMMON STOCK | CNE100000V20 | Not reported | 0.763% | $543K | Equity (common) | Other | China | CNY |
| 40 | CSPC Innovation Pharmaceutical Co Ltd CSPC INNOVATION PHARMACEUT-A COMMON STOCK | CNE100003K04 | Not reported | 0.742% | $529K | Equity (common) | Other | China | CNY |
| 41 | CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. CHANGCHUN HIGH-TECH INDUST-A COMMON STOCK | CNE0000007J8 | Not reported | 0.740% | $527K | Equity (common) | Other | China | CNY |
| 42 | Imeik Technology Development Co Ltd IMEIK TECHNOLOGY DEVELOPME-A COMMON STOCK | CNE100004868 | Not reported | 0.719% | $512K | Equity (common) | Other | China | CNY |
| 43 | APT Medical Inc APT MEDICAL INC-A COMMON STOCK | CNE100004C45 | Not reported | 0.698% | $497K | Equity (common) | Other | China | CNY |
| 44 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd BEIJING WANTAI BIOLOGICAL-A COMMON STOCK | CNE100004090 | Not reported | 0.672% | $479K | Equity (common) | Other | China | CNY |
| 45 | Hebei Changshan Biochemical Pharmaceutical Co Ltd HEBEI CHANGSHAN BIOCHEMICA-A COMMON STOCK | CNE1000016C2 | Not reported | 0.564% | $402K | Equity (common) | Other | China | CNY |
| 46 | Hangzhou Tigermed Consulting Co., Ltd HANGZHOU TIGERMED CONSULTI-A COMMON STOCK | CNE100001KV8 | Not reported | 0.455% | $324K | Equity (common) | Other | China | CNY |
| 47 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. ZHANGZHOU PIENTZEHUANG PHA-A COMMON STOCK | CNE000001F21 | Not reported | 0.077% | $55K | Equity (common) | Other | China | CNY |
| 48 | Sichuan Kelun Pharmaceutical Co., Ltd. SICHUAN KELUN PHARMACEUTIC-A COMMON STOCK | CNE100000PW7 | Not reported | 0.069% | $49K | Equity (common) | Other | China | CNY |
| 49 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. SHANGHAI FOSUN PHARMACEUTI-A COMMON STOCK | CNE000000X38 | Not reported | 0.063% | $45K | Equity (common) | Other | China | CNY |
| 50 | Shanghai Pharmaceuticals Holding Co., Ltd. SHANGHAI PHARMACEUTICALS-A COMMON STOCK | CNE000000C82 | Not reported | 0.036% | $25K | Equity (common) | Other | China | CNY |
| 51 | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. SHENZHEN SALUBRIS PHARM-A COMMON STOCK | CNE100000FW8 | Not reported | 0.036% | $25K | Equity (common) | Other | China | CNY |
| 52 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: USD/HKD SETTLE 2026-07-02 | Not reported | Not reported | −<0.001% | -$92 | Short-term investment vehicles (cash funds) | Other | United States | USD |
| 53 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: USD/HKD SETTLE 2026-07-02 | Not reported | Not reported | −<0.001% | -$57 | Short-term investment vehicles (cash funds) | Other | United States | USD |
| 54 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $24 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 55 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: USD/HKD SETTLE 2026-07-02 | Not reported | Not reported | −<0.001% | -$15 | Short-term investment vehicles (cash funds) | Other | United States | USD |
| 56 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $14 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 57 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $10 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 58 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $8 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 59 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $7 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 60 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $3 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 61 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $3 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 62 | BROWN BROTHERS HARRIMAN & CO. Spot FX Contract: HKD/USD SETTLE 2026-07-02 | Not reported | Not reported | <0.001% | $2 | Short-term investment vehicles (cash funds) | Other | Hong Kong | HKD |
| 63 | Unnamed position | Not reported | Not reported | 0.000% | $0 | Equity (common) | Other | United States | USD |